Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.
about
Emerging drugs for conjunctivitis.A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis.Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitisEmerging drugs for ocular allergy.Pharmacotherapy of allergic eye disease.Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis.Tacrolimus in the treatment of ocular diseases.Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis.Treatment of allergic children - Where is the progress (for the practicing allergist)?Topical tacrolimus in anterior segment inflammatory disorders.Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis.Management of vernal keratoconjunctivitis.Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
P2860
Q34999618-BE11DE16-9E80-4239-A40F-FB6119266124Q35171524-876EA4CA-F46D-46A3-9B3C-04E3CD471B89Q35226825-FA7B0300-2E22-46DB-8C18-0DDA51C730CDQ36219638-E32A0932-71AD-4219-8A84-6B78F6FFC862Q36491809-6FC7FC23-765C-4965-B837-BF29D0BC5F19Q36787750-2050EF97-E500-48DB-AE20-FC68152CABF8Q37858514-F02841F9-6054-488C-9132-40F804563378Q38040514-4184615A-0C15-485E-B944-9827EC2272BEQ38102592-BB72BA3F-C3D4-4C1C-A24E-2103C3C78626Q38179488-99567D81-17E7-4BC9-9E69-F7737A19576FQ38184630-525B0C6A-32D8-4B8D-92DE-4A8B7E4029D2Q38809512-D43344AB-8C78-4642-BB0D-73C6D712C714Q39175604-7064A5AC-B13E-4F13-8FE0-D1BAE0BB1AE7Q42716988-D8110663-4A50-41E1-9BD8-92A142936CA1Q42745061-16500F75-C019-4607-B80C-9E1C4C97B553Q46502349-AD943AEE-CF65-4165-88F4-E1CE3F3C68DCQ48048235-DC9B5C61-7C6F-43F4-92CF-B5045B8BCE6B
P2860
Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Vernal keratoconjunctivitis: R ...... al ophthalmic FK-506 ointment.
@en
Vernal keratoconjunctivitis: R ...... al ophthalmic FK-506 ointment.
@nl
type
label
Vernal keratoconjunctivitis: R ...... al ophthalmic FK-506 ointment.
@en
Vernal keratoconjunctivitis: R ...... al ophthalmic FK-506 ointment.
@nl
prefLabel
Vernal keratoconjunctivitis: R ...... al ophthalmic FK-506 ointment.
@en
Vernal keratoconjunctivitis: R ...... al ophthalmic FK-506 ointment.
@nl
P2093
P1476
Vernal keratoconjunctivitis: R ...... cal ophthalmic FK-506 ointment
@en
P2093
Chiraphan Tantimongkolsuk
Pakit Vichyanond
Panida Kosrirukvongs
Puttachart Dumrongkigchaiporn
P304
P356
10.1016/J.JACI.2003.10.065
P407
P577
2004-02-01T00:00:00Z